Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
4.99M
-
Number of holders
-
149
-
Total 13F shares, excl. options
-
101M
-
Shares change
-
+6.8M
-
Total reported value, excl. options
-
$593M
-
Value change
-
+$39.1M
-
Put/Call ratio
-
0.95
-
Number of buys
-
83
-
Number of sells
-
-52
-
Price
-
$5.86
Significant Holders of Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) as of Q4 2022
172 filings reported holding MRSN - Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q4 2022.
Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) has 149 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 101M shares
.
Largest 10 shareholders include ORBIMED ADVISORS LLC (9.01M shares), Bain Capital Life Sciences Investors, LLC (8.66M shares), Avoro Capital Advisors LLC (7.55M shares), BlackRock Inc. (7.49M shares), STATE STREET CORP (5.86M shares), VANGUARD GROUP INC (4.45M shares), Bellevue Group AG (4.28M shares), Rock Springs Capital Management LP (4.1M shares), Sarissa Capital Management LP (4M shares), and MILLENNIUM MANAGEMENT LLC (3.66M shares).
This table shows the top 149 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.